zenith laboratori inc state compani studi fourth fourth loss amount find complet year termin audit compani expand third fourth termin sept figur figur zenith account loss figur dlr figur per part set may figur figur stock split compani also state receiv food drug administr approv market cefadroxil gener version antibiot domest sale surpass figur mln dlr figur zenith state market drug question associ applic certain patent decid reuter